9v0v: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "9v0v" [edit=sysop:move=sysop] |
No edit summary Tag: Reverted |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 9v0v is ON HOLD | The entry 9v0v is ON HOLD until 2027-05-19 | ||
Authors: Yan, J., Feng, Y., Feng, Y.J. | Authors: Yan, J., Feng, Y., Feng, Y.J. | ||
| Line 7: | Line 7: | ||
Description: The top priority ESKAPE pathogens deploy flexible Sir2-HerA systems for anti-phage defense | Description: The top priority ESKAPE pathogens deploy flexible Sir2-HerA systems for anti-phage defense | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
[[Category: Yan, J]] | |||
[[Category: Feng, Y.J]] | [[Category: Feng, Y.J]] | ||
[[Category: Feng, Y]] | [[Category: Feng, Y]] | ||
Revision as of 04:21, 3 July 2025
Unreleased structure
The entry 9v0v is ON HOLD until 2027-05-19
Authors: Yan, J., Feng, Y., Feng, Y.J.
Description: The top priority ESKAPE pathogens deploy flexible Sir2-HerA systems for anti-phage defense
